These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 23778722
1. Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo. Nauta JJ. Eur Arch Otorhinolaryngol; 2014 May; 271(5):887-97. PubMed ID: 23778722 [Abstract] [Full Text] [Related]
2. Betahistine in Ménière's Disease or Syndrome: A Systematic Review. Van Esch B, van der Zaag-Loonen H, Bruintjes T, van Benthem PP. Audiol Neurootol; 2022 May; 27(1):1-33. PubMed ID: 34233329 [Abstract] [Full Text] [Related]
5. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence. Devantier L, Hougaard D, Händel MN, Liviu-Adelin Guldfred F, Schmidt JH, Djurhuus B, Callesen HE. Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600 [Abstract] [Full Text] [Related]
6. Betahistine for Menière's disease or syndrome. James AL, Burton MJ. Cochrane Database Syst Rev; 2001 Oct; 2001(1):CD001873. PubMed ID: 11279734 [Abstract] [Full Text] [Related]
7. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M, BEMED Study Group. BMJ; 2016 Jan 21; 352():h6816. PubMed ID: 26797774 [Abstract] [Full Text] [Related]
8. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study]. Kluyskens P, Lambert P, D'Hooge D. Ann Otolaryngol Chir Cervicofac; 1990 Jan 21; 107 Suppl 1():11-9. PubMed ID: 2240994 [Abstract] [Full Text] [Related]
10. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results. Casani AP, Guidetti G, Schoenhuber R, Consensus Conference Group. Acta Otorhinolaryngol Ital; 2018 Oct 21; 38(5):460-467. PubMed ID: 30498275 [Abstract] [Full Text] [Related]
11. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study. Oosterveld WJ. J Laryngol Otol; 1984 Jan 21; 98(1):37-41. PubMed ID: 6363584 [Abstract] [Full Text] [Related]
12. Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière's disease compared with betahistine pharmacotherapy. Molnár A, Maihoub S, Tamás L, Szirmai Á. J Int Med Res; 2021 Apr 21; 49(4):300060520985647. PubMed ID: 33845616 [Abstract] [Full Text] [Related]
13. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study. Novotný M, Kostrica R. Int Tinnitus J; 2002 Apr 21; 8(2):115-23. PubMed ID: 14763223 [Abstract] [Full Text] [Related]